MENU
+Compare
RXST
Stock ticker: NASDAQ
AS OF
Apr 3 closing price
Price
$16.21
Change
-$9.91 (-37.94%)
Capitalization
1.91B

RXST RxSight Forecast, Technical & Fundamental Analysis

RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery... Show more

RXST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for RXST with price predictions
Apr 03, 2025

Momentum Indicator for RXST turns negative, indicating new downward trend

RXST saw its Momentum Indicator move below the 0 level on April 03, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 71 similar instances where the indicator turned negative. In of the 71 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for RXST turned negative on April 03, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RXST declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for RXST entered a downward trend on April 01, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for RXST's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 41 cases where RXST's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RXST advanced for three days, in of 220 cases, the price rose further within the following month. The odds of a continued upward trend are .

RXST may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.641) is normal, around the industry mean (23.715). P/E Ratio (15.267) is within average values for comparable stocks, (83.458). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (19.531) is also within normal values, averaging (41.612).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. RXST’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RXST’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock worse than average.

View a ticker or compare two or three
RXST
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

RXST is expected to report earnings to fall 764.33% to -19 cents per share on May 13

RxSight RXST Stock Earnings Reports
Q1'25
Est.
$-0.20
Q4'24
Beat
by $0.20
Q3'24
Beat
by $0.09
Q2'24
Beat
by $0.06
Q1'24
Beat
by $0.17
The last earnings report on February 25 showed earnings per share of 2 cents, beating the estimate of -17 cents. With 5.73M shares outstanding, the current market capitalization sits at 1.91B.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
100 Columbia
Phone
+1 949 521-7830
Employees
374
Web
https://www.rxsight.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DFVIX19.68N/A
N/A
DFA International Value III
NEFFX58.61N/A
N/A
American Funds New Economy F2
TBDCX10.79N/A
N/A
PGIM Jennison Diversified Growth C
MDRFX20.93N/A
N/A
BlackRock Mid-Cap Value Investor A
LSPIX5.56N/A
N/A
LoCorr Spectrum Income I

RXST and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RXST has been loosely correlated with GKOS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if RXST jumps, then GKOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXST
1D Price
Change %
RXST100%
-37.94%
GKOS - RXST
43%
Loosely correlated
-13.03%
ESTA - RXST
39%
Loosely correlated
-18.59%
SONVY - RXST
36%
Loosely correlated
-1.80%
TRUMY - RXST
34%
Loosely correlated
-2.81%
KIDS - RXST
34%
Loosely correlated
-10.11%
More